Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure
Jorge Cortes*, Alfonso Quintás-Cardama, Guillermo Garcia-Manero, Susan O'Brien, Dan Jones, Stefan Faderl, Theresa Ebarb, Francis Giles, Deborah Thomas, Hagop Kantarjian
Dive into the research topics of 'Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure'. Together they form a unique fingerprint.